[1]
Armstrong, A.W., Bissonnette, R., Brown, P.M., Tallman, A.M. and Papp, K.A. 2022. Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s52. DOI:https://doi.org/10.25251/skin.6.supp.52.